Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
about
Severe thrombocytopenia associated with alatrofloxacin.Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura.New insights and therapeutics for immune-mediated thrombocytopenia.Epidemiology and pathophysiology of immune thrombocytopenic purpura.Emerging strategies to treat chronic immune thrombocytopenic purpura.Refractory immune thrombocytopenic purpura: current strategies for investigation and management.Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura.Thrombopoietin and platelet production in chronic immune thrombocytopenia.New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research DatabaseMoving towards a new era in the management of chronic immune thrombocytopenia.Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principleThe emotional consequences of corticosteroid use in hematology: preliminary findings.Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.The pathophysiology, diagnosis and management of autoimmune thrombocytopenia.Current treatment options for primary immune thrombocytopenia.Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.Therapeutic options for immune-mediated thrombocytopenia.Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopeniaProlonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpura.Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesSpontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.Alternate considerations for current concepts in ITP.Contemporary treatment of immune thrombocytopenia.Milestones in understanding platelet production: a historical overview.Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRANSuppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesThe management of immune thrombocytopenic purpura.Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients.Autoimmune thrombocytopenic purpura in pregnancy: maternal risk factors predictive of neonatal thrombocytopenia.Post-splenectomy response in adult patients with immune thrombocytopenic purpura.A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag.Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura.
P2860
Q33333327-FA514AD4-F021-40CE-A12C-7C4F619A60C0Q33336459-E540B087-C464-4366-BE7D-A8F0C14CE73AQ33377901-4545D2E3-9B58-4D0B-A77D-78603498C761Q33378367-9FB0423C-3030-404C-BF76-CD584D31EA36Q33378375-1A58D247-F7AD-4FB8-9C00-B22DA3ECA97CQ33380052-823F8390-0171-4F8B-9339-A88E48866F03Q33380673-2A5B2189-786A-4833-AE51-16CC80A5595BQ33387153-83463A41-631A-4C35-A30E-7244E3DFBA64Q33387735-06B0B7F0-E2D1-4F65-92CE-926805537F03Q33388213-8A8F1009-4756-49D8-B57E-7437A0448C3AQ33388944-1932E415-9ACC-401E-8F26-8C4726DBAF17Q33390001-8CC9FE19-98D0-4BBB-99CF-0D357835B6E8Q33390687-1615BB94-385E-4D63-8DA7-C9B8198B2F02Q33391229-F3AAD235-9B0B-43C8-B050-E7D4D7646E85Q33392632-D36B3BF8-E30E-4152-8571-B59C606D93D7Q33394149-02511C72-12AB-4570-8ADC-C34317D6474CQ33394438-BE52AC5D-F76B-4147-8792-7652189F814AQ33398568-B2D2D20A-05A5-4281-99D8-48D20ED6D73EQ33399601-94983B06-D78A-4A4B-A285-F2D799BCF1C8Q33400722-34A029EA-CCB0-407A-988C-CE005BD0F96CQ33402617-0BDB7496-7183-4240-A088-6EEB1E9786D2Q33402843-1A31C10A-1F84-4F0E-A85E-E2AD8EADA637Q33403517-124B87C6-F36F-4C5F-B7FC-CACC9B265D41Q33404073-C7A65575-437A-46B9-B9BE-23CB808A9C67Q33407813-2EA48634-A00D-4CDC-AA09-1183857CB7D9Q33410653-9400E9FB-C032-44A8-A800-9805883BDA3DQ33413326-2EF87D9E-0616-4498-9B13-7AA61136A7A7Q33414365-26F6D550-9F24-45FD-AA1E-999EC95ADEBCQ33420128-01F801CE-549B-48BD-ADB2-8EBCE2FDFEEDQ33424728-72B1128B-CA5B-41CA-9F05-A31D1EA8B3F3Q33428804-FA7920F4-A6BC-45F0-BEEA-CFCCA3B3083BQ33490242-2E2FE851-9127-4ECD-8B26-43D4DFD303ECQ33491513-D17CCBF0-76D5-4DAC-AB91-B1812881D5AFQ41911253-A5691420-D9CB-4525-B312-282F040412C7Q47175210-3D6A4277-BA96-405D-9FBF-71039F273164Q47720114-7A8E25EC-89A7-4426-B981-AFDE44D2AA42
P2860
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
@ast
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
@en
type
label
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
@ast
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
@en
prefLabel
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
@ast
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
@en
P2093
P1476
Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
@en
P2093
Gernsheimer T
Slichter SJ
Stratton J
P304
P356
10.1056/NEJM198904133201505
P407
P577
1989-04-01T00:00:00Z